BRPI0718131A2 - Cristal de carbamato de (s)-(+)-2-(2-clorofenil)-hidróoxi-etila - Google Patents

Cristal de carbamato de (s)-(+)-2-(2-clorofenil)-hidróoxi-etila

Info

Publication number: BRPI0718131A2
Authority: BR; Brazil
Prior art keywords: chlorophenyl; hydroxy; crystal; ethyl carbamate; carbamate
Prior art date: 2006-10-06

Application number

BRPI0718131-0A2A

Other languages

English (en)

Inventor

Matthew Peterson

Original Assignee

Transform Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-06

Filing date

2007-10-05

Publication date

2013-11-05

2007-10-05 Application filed by Transform Pharmaceuticals Inc filed Critical Transform Pharmaceuticals Inc

2013-11-05 Publication of BRPI0718131A2 publication Critical patent/BRPI0718131A2/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Liquid Crystal Substances (AREA)

BRPI0718131-0A2A 2006-10-06 2007-10-05 Cristal de carbamato de (s)-(+)-2-(2-clorofenil)-hidróoxi-etila BRPI0718131A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US82839206P	2006-10-06	2006-10-06
PCT/US2007/021502 WO2008045391A2 (en)	2006-10-06	2007-10-05	Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate

Publications (1)

Publication Number	Publication Date
BRPI0718131A2 true BRPI0718131A2 (pt)	2013-11-05

Family

ID=39283405

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0718131-0A2A BRPI0718131A2 (pt)	2006-10-06	2007-10-05	Cristal de carbamato de (s)-(+)-2-(2-clorofenil)-hidróoxi-etila

Country Status (19)

Country	Link
US (1)	US7632963B2 (pt)
EP (1)	EP2076258A4 (pt)
JP (1)	JP2010505856A (pt)
KR (1)	KR20090076958A (pt)
CN (1)	CN101657195A (pt)
AU (1)	AU2007307029A1 (pt)
BR (1)	BRPI0718131A2 (pt)
CA (1)	CA2665573A1 (pt)
CO (1)	CO6180504A2 (pt)
CR (1)	CR10764A (pt)
EA (1)	EA200970355A1 (pt)
GT (1)	GT200900076A (pt)
IL (1)	IL198016A0 (pt)
MX (1)	MX2009003755A (pt)
NI (1)	NI200900050A (pt)
NO (1)	NO20091771L (pt)
SV (1)	SV2009003211A (pt)
WO (1)	WO2008045391A2 (pt)
ZA (1)	ZA200903095B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
EP2797880B1 (en) *	2011-12-27	2017-03-01	Bio-Pharm Solutions Co., Ltd.	Phenyl carbamate compounds for use in preventing or treating epilepsy
KR102399807B1 (ko) *	2021-08-05	2022-05-20	(주)바이오팜솔루션즈	페닐카바메이트 결정형 및 이의 제조 방법
WO2023014160A1 (ko) *	2021-08-05	2023-02-09	(주)바이오팜솔루션즈	페닐카바메이트 결정형 및 이의 제조 방법
US12054449B2 (en)	2021-08-05	2024-08-06	Bio-Pharm Solutions Co., Ltd.	Phenylcarbamate crystalline form and method for manufacturing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
CA2349663C (en) *	1999-09-10	2006-10-31	Dainippon Ink And Chemicals, Inc.	Quinolinone derivative formulation and its production method
PL364680A1 (en) *	2001-02-27	2004-12-13	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating neurodegenerative disorders
HRP20040557A2 (en) *	2001-12-21	2005-04-30	Ortho-Mcneil Pharmaceutical	Process for preparing 2-(substituted phenyl)-2-hydroxy carbamates
PL1658277T3 (pl) *	2003-08-18	2012-10-31	H Lundbeck As	Sól bursztynianowa i malonianowa trans-4-((1R,3S)-6-chloro-3-fenyloindan-1-ylo)-1,2,2-tri-metylopiperazyny i zastosowanie jako lek
CA2580640A1 (en) *	2004-09-16	2006-03-30	Janssen Pharmaceutica N.V.	Methods of treating epileptogensis and epilepsy
US20070021500A1 (en) *	2005-07-12	2007-01-25	Twyman Roy E	Methods for neuroprotection

2007
- 2007-10-05 CN CN200780045483A patent/CN101657195A/zh active Pending
- 2007-10-05 US US11/867,803 patent/US7632963B2/en not_active Expired - Fee Related
- 2007-10-05 EA EA200970355A patent/EA200970355A1/ru unknown
- 2007-10-05 AU AU2007307029A patent/AU2007307029A1/en not_active Abandoned
- 2007-10-05 WO PCT/US2007/021502 patent/WO2008045391A2/en not_active Ceased
- 2007-10-05 MX MX2009003755A patent/MX2009003755A/es active IP Right Grant
- 2007-10-05 CA CA002665573A patent/CA2665573A1/en not_active Abandoned
- 2007-10-05 BR BRPI0718131-0A2A patent/BRPI0718131A2/pt not_active IP Right Cessation
- 2007-10-05 EP EP07839353A patent/EP2076258A4/en not_active Withdrawn
- 2007-10-05 KR KR1020097009191A patent/KR20090076958A/ko not_active Withdrawn
- 2007-10-05 JP JP2009531487A patent/JP2010505856A/ja not_active Withdrawn
2009
- 2009-04-03 SV SV2009003211A patent/SV2009003211A/es not_active Application Discontinuation
- 2009-04-03 NI NI200900050A patent/NI200900050A/es unknown
- 2009-04-05 IL IL198016A patent/IL198016A0/en unknown
- 2009-04-06 GT GT200900076A patent/GT200900076A/es unknown
- 2009-04-07 CO CO09035814A patent/CO6180504A2/es not_active Application Discontinuation
- 2009-05-05 ZA ZA200903095A patent/ZA200903095B/xx unknown
- 2009-05-05 CR CR10764A patent/CR10764A/es not_active Application Discontinuation
- 2009-05-05 NO NO20091771A patent/NO20091771L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN101657195A (zh)	2010-02-24
AU2007307029A1 (en)	2008-04-17
CR10764A (es)	2009-09-14
KR20090076958A (ko)	2009-07-13
ZA200903095B (en)	2010-07-28
IL198016A0 (en)	2009-12-24
SV2009003211A (es)	2009-11-24
CA2665573A1 (en)	2008-04-17
GT200900076A (es)	2010-05-18
JP2010505856A (ja)	2010-02-25
EA200970355A1 (ru)	2009-12-30
US7632963B2 (en)	2009-12-15
WO2008045391A3 (en)	2008-06-12
EP2076258A4 (en)	2011-09-28
NI200900050A (es)	2010-02-01
WO2008045391A2 (en)	2008-04-17
CO6180504A2 (es)	2010-07-19
MX2009003755A (es)	2009-07-10
US20080085930A1 (en)	2008-04-10
EP2076258A2 (en)	2009-07-08
NO20091771L (no)	2009-05-05

Legal Events

Date	Code	Title	Description
2014-08-26	B08L	Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]	Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 5A, 6A E 7A ANUIDADES.
2020-11-10	B08I	Publication cancelled [chapter 8.9 patent gazette]	Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.
2020-11-17	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES.
2021-03-09	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
EP1779444A4 (en)	2011-01-05	TUNABLE PHOTONIC CRYSTAL
CY2016029I2 (el)	2017-04-26	Πρωτεϊνες συνδεσης αντιγονου προς προπρωτεϊνη κονβερτασης σουμπτιλισινης κεχιν τυπου 9(pcsk9)
EP2022767A4 (en)	2009-05-06	KRISTALLGLAS SUBJECT
DE502006003629D1 (de)	2009-06-10	Lastschaltbares gruppengetriebe
EP2077901A4 (en)	2011-06-29	OKULAR RADIOSURGERY
DE602005001664D1 (de)	2007-08-30	Optischer Entfernungsmesser
DE602005005030D1 (de)	2008-04-10	Stufenloses riemengetriebe
FI20055630A0 (fi)	2005-11-30	Kasvonaamio
EP1993006A4 (en)	2009-05-13	CHRONOGRAPH WATCH
BRPI0718131A2 (pt)	2013-11-05	Cristal de carbamato de (s)-(+)-2-(2-clorofenil)-hidróoxi-etila
EP1940406A4 (en)	2009-11-18	POTASSIUM CHANNEL INHIBITORS
DE502005005664D1 (de)	2008-11-27	Chronograph
DE112007002678A5 (de)	2009-08-20	Uhrengehäuse
DE112006003808A5 (de)	2009-01-02	Halteschlaufe
BRPI0717824A2 (pt)	2014-04-15	Cristal de carbamato de (s)-(+)-2-(2-clorofenil)-2-hidróxi-etila
EP1776355A4 (en)	2009-08-12	POTASSIUM CHANNEL INHIBITORS
DE502005003827D1 (de)	2008-06-05	Zahnrad
DE112005001381T5 (de)	2007-05-16	Gangschaltungssystem
EP1954626A4 (en)	2011-05-04	MULTI-FUNCTIONAL NANOSTRUCTURE AND METHOD
DK1723278T3 (da)	2007-12-27	Multiaksialt kompleks
FR2877833B1 (fr)	2007-10-12	Correcteur de lordoses
FR2908664B3 (fr)	2008-11-07	Lunettes de natation
FI20040753A0 (fi)	2004-06-02	Turvaväline
ES1064213Y (es)	2007-05-16	Gafas de natacion
ES1062437Y (es)	2006-09-16	Gafas de natacion